Longitude Venture Partners III, L.P.
Insider CIK 1674099 · MTEM 10% owner · SRRA 10% owner · AXNX 10% owner · INZY 10% owner · ETNB 10% owner · TALS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 1,964,771 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 588 | — | $0 | 5,611 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 840 | — | $0 | 8,015 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 252 | — | $0 | 2,404 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 175,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 7,175 | — | $0 | 7,175 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 5,023 | — | $0 | 5,023 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 2,152 | — | $0 | 2,152 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2022-04-19 | 2022-04-21 | 1,355,000 | $3.69 | $5.00M | 4,174,379 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2022-02-02 | 2022-02-02 | 175,000 | $27.00 | $4.72M | 175,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-25 | 2022-01-27 | 1,477,125 | $13.20 | $19.50M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-25 | 2022-01-27 | 487,451 | $13.20 | $6.43M | 1,964,771 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 1,271,027 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 1,308,410 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 406,338 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-11 | 235,000 | $17.00 | $4.00M | 3,220,775 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-11 | 2,985,775 | — | $0 | 2,985,775 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 891 | — | $0 | 891 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 850,000 | — | $0 | 1,750,877 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 2,080 | — | $0 | 2,080 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 2,973 | — | $0 | 2,973 | SEC↗ |
| MTEM Molecular Templates, Inc. | S Sale | 2020-08-28 | 2020-09-01 | 1,049 | $10.75 | $11.3K | 0 | SEC↗ |
| MTEM Molecular Templates, Inc. | S Sale | 2020-08-28 | 2020-09-01 | 2,447 | $10.75 | $26.3K | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 1,398,600 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 15,000,000 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 187,154 | — | $0 | 2,194,379 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 625,000 | $16.00 | $10.00M | 2,819,379 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 2,007,225 | — | $0 | 2,007,225 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2020-07-10 | 2020-07-14 | 109,090 | $27.50 | $3.00M | 2,600,877 | SEC↗ |
| MTEM Molecular Templates, Inc. | J Other | 2020-05-26 | 2020-05-28 | 1,000,000 | — | $0 | 3,199,035 | SEC↗ |
| MTEM Molecular Templates, Inc. | J Other | 2020-05-26 | 2020-05-28 | 3,495 | — | $0 | 3,495 | SEC↗ |
| MTEM Molecular Templates, Inc. | J Other | 2020-05-26 | 2020-05-28 | 2,447 | — | $0 | 2,447 | SEC↗ |
| MTEM Molecular Templates, Inc. | J Other | 2020-05-26 | 2020-05-28 | 1,049 | — | $0 | 1,049 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 19,500 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 1,477,320 | — | $0 | 1,477,320 | SEC↗ |
| MTEM Molecular Templates, Inc. | P Buy | 2019-11-25 | 2019-11-27 | 937,000 | $8.00 | $7.50M | 4,198,535 | SEC↗ |
| MTEM Molecular Templates, Inc. | P Buy | 2019-11-25 | 2019-12-05 | 937,500 | $8.00 | $7.50M | 4,199,035 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 11,916,667 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 1,916,787 | — | $0 | 2,491,787 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 575,000 | $16.00 | $9.20M | 575,000 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion deriv | 2018-11-02 | 2018-11-02 | 2,000,000 | — | $0 | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | P Buy | 2018-11-02 | 2018-11-02 | 533,333 | $15.00 | $8.00M | 2,933,333 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion | 2018-11-02 | 2018-11-02 | 2,400,000 | — | $0 | 2,400,000 | SEC↗ |
| MTEM Molecular Templates, Inc. | P Buy | 2018-09-21 | 2018-09-25 | 365,000 | $5.50 | $2.01M | 3,261,535 | SEC↗ |